Martin Skovmos Nielsen

Martin Skovmos Nielsen

Auto-generated profile, based on publicly available information

Martin Skovmos Nielsen

Department of Oncology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2012 in International Journal of Radiation Oncology - Biology - Physics (IJROBP)
Verified
Journal Article
Closed access
PDF file
PPPer Rugaard Poulsen
Per Rugaard Poulsen
JCJesper Carl
Jesper Carl
JNJane Nielsen
Jane Nielsen
MNMartin S. Nielsen
Martin S. Nielsen
JTJakob B. Thomsen
Jakob B. Thomsen
PKPaul J. Keall
Paul J. Keall

13 September 2023 in Acta Oncologica
Verified
Journal Article
Closed access
CNCamilla Panduro Nielsen
Camilla Panduro Nielsen
ELEbbe Laugaard Lorenzen
Ebbe Laugaard Lorenzen
KJKenneth Jensen
Kenneth Jensen
NSNis Sarup
Nis Sarup
CBCarsten Brink
Carsten Brink
CHChristian Rønn Hansen
Christian Rønn Hansen
In the Danish Head and Neck Cancer Group (DAHANCA) 35 trial, patients are selected for proton treatment based on simulated reductions of Normal Tissue Complication Probability (NTCP) for proton compared to photon treatment at the referring departments. After inclusion in the trial, immobilization, scanning, contouring and planning are repeated at the national proton centre. The new contours could result in reduced expected NTCP gain of the proton plan, resulting in a loss of validity in the selection process. The present study evaluates if contour consistency can be improved by having access to AI (Artificial Intelligence) based contours. The 63 patients in the DAHANCA 35 pilot trial had a CT from the local DAHANCA centre and one from the proton centre. A nationally validated convolutional neural network, based on nnU-Net, was used to contour OARs on both scans for each patient. Using deformable image registration, local AI and oncologist contours were transferred to the proton centre scans for comparison. Consistency was calculated with the Dice Similarity Coefficient (DSC) and Mean Surface Distance (MSD), comparing contours from AI to AI and oncologist to oncologist, respectively. Two NTCP models were applied to calculate NTCP for xerostomia and dysphagia. The AI contours showed significantly better consistency than the contours by oncologists. The median and interquartile range of DSC was 0.85 [0.78 - 0.90] and 0.68 [0.51 - 0.80] for AI and oncologist contours, respectively. The median and interquartile range of MSD was 0.9 mm [0.7 - 1.1] mm and 1.9 mm [1.5 - 2.6] mm for AI and oncologist contours, respectively. There was no significant difference in ΔNTCP. The study showed that OAR contours made by the AI algorithm were more consistent than those made by oncologists. No significant impact on the ΔNTCP calculations could be discerned.

24 July 2025 in Acta Oncologica
Verified
Journal Article
Open access
PDF file
LKLaura P. Kaplan
Laura P. Kaplan
RTRebecca J. Tobin
Rebecca J. Tobin
AAAne Appelt
Ane Appelt
EOEliana Vasquez Osorio
Eliana Vasquez Osorio
IWIsak Wahlstedt
Isak Wahlstedt
LHLone Hoffmann
Lone Hoffmann
Background and purpose: Reirradiation is becoming more frequent in clinical practice. However, workflows and practices vary widely between clinics, as general guidelines are scarce or lacking in practical detail. This paper presents comprehensive national Danish consensus recommendations covering all steps of the reirradiation workflow. The aim is to standardise and improve reirradiation treatment quality and provide guidance for much-needed large-scale clinical trials. Methods: An expert panel was formed comprising physicians, clinical physicists, and clinical researchers from all Danish radiotherapy centres. An in-person 2-day workshop was followed by multiple online meetings. Recommendations were based on expert consensus, supported by review of existing literature, and were reviewed by all Danish Multidisciplinary Cancer Groups before publication. Results: Reirradiation cases should be designated clearly as such at each workflow step. Review of patient cases at multidisciplinary reirradiation conferences is encouraged. Immobilisation, positioning, and motion management should resemble that of previous treatment(s) as closely as possible. Information on previous dose should be used in planning and evaluation. The degree of complexity (e.g. summation of dose maxima, rigid/deformable image registration, 3D dose accumulation) should reflect the clinical situation as well as the extent/quality of available information. Dose should always be converted to an equieffective dose before summation. Daily image-guidance and regular evaluation of delivered dose are recommended. We provide guidance on quality assurance of dose mapping and guidelines for clinical reirradiation trials. Interpretation: We present national consensus guidelines for site-independent reirradiation treatment workflows. The guidelines have been approved by the site-specific Danish Multidisciplinary Cancer Groups.

3 January 2022 in Acta Oncologica
Verified
Journal Article
Closed access
MSMaja B. Sharma
Maja B. Sharma
KJKenneth Jensen
Kenneth Jensen
JFJeppe Friborg
Jeppe Friborg
BSBob Smulders
Bob Smulders
EAElo Andersen
Elo Andersen
CGCai Grau
Cai Grau
The study aimed to investigate the pattern of failure and describe compromises in the definition and coverage of the target for patients treated with curatively intended radiotherapy (RT) for sinon...

6 February 2026 in Acta Oncologica
Verified
Journal Article
Open access
CGChristoffer Sander Graven-Nielsen
Christoffer Sander Graven-Nielsen
AKAnna Jakobsen Kragh
Anna Jakobsen Kragh
RBRasmus Froberg Brøndum
Rasmus Froberg Brøndum
MMMarie Louise Milo
Marie Louise Milo
MNMartin Skovmos Nielsen
Martin Skovmos Nielsen
WSWeronika Maria Szejniuk
Weronika Maria Szejniuk
Background and purpose: Radiotherapy (RT) is a key treatment for locally advanced non-small cell lung cancer (NSCLC). Tumours near the heart may result in unintended cardiac radiation exposure, increasing the risk of cardiotoxicity, such as de novo atrial fibrillation (DNAF) and de novo heart diseases (DNHD) as ischemic heart disease, heart failure, arterial hypertension or sudden cardiac death. This study investigated associations between radiation dose to cardiac substructures and risk of DNAF and DNHD.Patient/material and methods: This retrospective cohort study included patients treated between January 1, 2010, and December 31, 2020 for NSCLC with definitive RT. The heart, right atrium (RA) and sinoatrial node (SAN) were delineated. Associations between dose-volume parameters and cardiac outcomes were analysed using multivariable models adjusted for relevant confounders. Kaplan-Meier curves estimated survival; p-values < 0.05 were significant.Results: Among 273 included patients, 9.5% had AF pre-RT and 12.8% developed DNAF. DNAF was significantly associated with SAN Dmax (hazard ratio [HR] = 1.01), RA Dmax (HR = 1.02), RA Dmean (HR = 1.03), mean heart dose (MHD) (HR = 1.04) and heart V40Gy (HR = 1.03). One-year probabilities of DNAF and DNHD were 9.3% and 11%, increasing to 12.2% and 13.2% at 2 years. DNHD was significantly associated with SAN Dmax (HR = 1.02), RA Dmax (HR = 1.02), RA Dmean (HR = 1.04), MHD (HR = 1.06), heart V25Gy (HR = 1.03) and V40Gy (HR = 1.03). Interpretation: The RA and SAN may be considered organs at risk in future RT planning. Minimising cardiac radiation is important to reduce DNAF and DNHD risk. Validation in an independent cohort is warranted.

3 July 2015 in Acta Oncologica
Verified
Journal Article
Closed access
PDF file
MNMartin S. Nielsen
Martin S. Nielsen
LØLasse R. Østergaard
Lasse R. Østergaard
JCJesper Carl
Jesper Carl
A new method to validate thoracic CT-CT deformable image registration using auto-segmented 3D anatomical landmarks. . ???aop.label???.